Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Erdmann

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Medicinal Chemistry|December 1, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma ActivityTino Heimburg, Fiona R Kolbinger, Patrik Zeyen, et al.
Journal of Medicinal Chemistry|November 30, 2022
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory PropertiesPing Sun, Jing Wang, Khadija S Khan, et al.
European Journal of Medicinal Chemistry|March 20, 2022
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cellsPatrik Zeyen, Yanira Zeyn, Daniel Herp, et al.
International Journal of Molecular Sciences|January 11, 2022
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic ActivityHany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.
Molecular Cancer|May 29, 2023
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancerSandra Kendzia, Susanne Franke, Tarek Kröhler, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Medicinal Chemistry|December 1, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma ActivityTino Heimburg, Fiona R Kolbinger, Patrik Zeyen, et al.
Journal of Medicinal Chemistry|November 30, 2022
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory PropertiesPing Sun, Jing Wang, Khadija S Khan, et al.
European Journal of Medicinal Chemistry|March 20, 2022
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cellsPatrik Zeyen, Yanira Zeyn, Daniel Herp, et al.
International Journal of Molecular Sciences|January 11, 2022
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic ActivityHany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.
Molecular Cancer|May 29, 2023
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancerSandra Kendzia, Susanne Franke, Tarek Kröhler, et al.
Pageof 7